Founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group PLC, with historical roots dating back to 1913, AstraZeneca plc is a global, science-led biopharmaceutical company headquartered in Cambridge, England, at the Cambridge Biomedical Campus. The company is focused on the research, development, and commercialization of prescription medicines across oncology, biopharmaceuticals, vaccines and immune therapies, and rare disease, supported by a broad international platform for scientific innovation. As of December 31, 2025, AstraZeneca employed approximately 96,100 people worldwide, operated six global strategic R&D centres in Cambridge, Gaithersburg, Boston, Gothenburg, Shanghai, and Beijing, and reported total revenue of USD 58.7 billion for 2025.
Updated 2026-03-19